Expanding Access to Multiple Myeloma Clinical Trials With Douglas Sborov

Douglas Sborov, MD, MS, Director of the Multiple Myeloma Program, Huntsman Cancer Institute at the University of Utah, speaks about recent initiatives to expand eligibility to multiple myeloma clinical trials, and the challenges this may present.